Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Suzuken Co ( (JP:9987) ) just unveiled an update.
Suzuken Co., Ltd. has announced the results of its share repurchase program for June 2025, acquiring 427,800 common shares for approximately ¥2.29 billion through market purchases on the Tokyo Stock Exchange. This activity is part of a larger plan to repurchase up to 5.2 million shares, representing 7.21% of total shares outstanding, by March 2026, with a total budget of ¥26 billion. The repurchase aims to enhance shareholder value and optimize capital structure.
The most recent analyst rating on (JP:9987) stock is a Hold with a Yen5730.00 price target. To see the full list of analyst forecasts on Suzuken Co stock, see the JP:9987 Stock Forecast page.
More about Suzuken Co
Suzuken Co., Ltd. operates in the pharmaceutical industry, primarily focusing on the distribution of pharmaceuticals and medical devices. The company is publicly traded on the Tokyo, Nagoya, and Sapporo Stock Exchanges.
Average Trading Volume: 227,085
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen296B
Learn more about 9987 stock on TipRanks’ Stock Analysis page.